Cornelis M de Mooij

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Neoadjuvant Chemotherapy

Locally Advanced

Sentinel Lymph Node

Top Venues

EJNMMI research

The British journal of surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Florien J G van Amstel, Cornelis M de Mooij, Janine M Simons, Cristina Mitea, Paul J van Diest, Patty J Nelemans, Carmen C van der Pol, Ernest J T Luiten, Linetta B Koppert, Marjolein L Smidt, Thiemo J A van Nijnatten, null null
Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer. The British journal of surgery 111 (9) (2024)
Cornelis M de Mooij, Thiemo J A van Nijnatten, Briete Goorts, Loes F S Kooreman, Isabel W M Raymakers, Silke P L van Meijl, Maaike de Boer, Kristien B M I Keymeulen, Joachim E Wildberger, Felix Manuel Mottaghy, Marc B I Lobbes, Marjolein L Smidt
Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer. Cancers 15 (2) (2023)
Cornelis M de Mooij, Roxanne A W Ploumen, Patty J Nelemans, Felix M Mottaghy, Marjolein L Smidt, Thiemo J A van Nijnatten
The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis. EJNMMI research 13 (1) (2023)
Cornelis M de Mooij, Thiemo J A van Nijnatten, Briete Goorts, Loes F S Kooreman, Isabel W M Raymakers, Silke P L van Meijl, Maaike de Boer, Kristien B M I Keymeulen, Joachim E Wildberger, Felix Manuel Mottaghy, Marc B I Lobbes, Marjolein L Smidt
Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer. Cancers 15 (2) (2023)
Cornelis M de Mooij, Roxanne A W Ploumen, Patty J Nelemans, Felix M Mottaghy, Marjolein L Smidt, Thiemo J A van Nijnatten
The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis. EJNMMI research 13 (1) (2023)
Cornelis M de Mooij, Thiemo J A van Nijnatten, Briete Goorts, Loes F S Kooreman, Isabel W M Raymakers, Silke P L van Meijl, Maaike de Boer, Kristien B M I Keymeulen, Joachim E Wildberger, Felix Manuel Mottaghy, Marc B I Lobbes, Marjolein L Smidt
Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer. Cancers 15 (2) (2023)
Cornelis M de Mooij, Roxanne A W Ploumen, Patty J Nelemans, Felix M Mottaghy, Marjolein L Smidt, Thiemo J A van Nijnatten
The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis. EJNMMI research 13 (1) (2023)
Cornelis M de Mooij, Roxanne A W Ploumen, Patty J Nelemans, Felix M Mottaghy, Marjolein L Smidt, Thiemo J A van Nijnatten
The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis. EJNMMI research 13 (1) (2023)
Cornelis M de Mooij, Cristina Mitea, Felix M Mottaghy, Marjolein L Smidt, Thiemo J A van Nijnatten
Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype. EJNMMI research 11 (1) (2021)